"Any Indication could be referring to VIRALEZE™ as well as Vivagel™ BV
The above extracts from TGA would allow for mainstream advertising"
This in the future may allow advertising but it will still be restricted to advertising for which specific approval was achieved and also will need to have data , tests and trials etc to support any claims made ian any for of advertisment.
This isn't open slather and as seen by $93,000 fine and payment of fine SPL has sailed too close to the wind , crossed the line and / or made errors in its understanding of allowed conduct. Yes it is a worldwid emarketplace but it really looked like IMO a amateur mistake not geobloking sites and advertisments in a suitable manner to stay compliant. TGA can still apply specific controls, restrictions over individual product , product groups device, medicine etc etc.
We have no idea if TGA will continue to accept that SPL products do fit the box as a device and due and that may have consequences beyond just SPL and it's products. There is always risk.
- Forums
- ASX - By Stock
- SPL
- Ann: US patent issued for DEP cabazitaxel nanoparticle
Ann: US patent issued for DEP cabazitaxel nanoparticle, page-40
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add SPL (ASX) to my watchlist
|
|||||
Last
9.5¢ |
Change
0.004(4.40%) |
Mkt cap ! $39.17M |
Open | High | Low | Value | Volume |
9.2¢ | 9.6¢ | 9.2¢ | $81.30K | 864.2K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 28056 | 9.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
9.9¢ | 1285 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 28056 | 0.095 |
2 | 110498 | 0.094 |
1 | 26688 | 0.092 |
1 | 49413 | 0.091 |
4 | 122750 | 0.090 |
Price($) | Vol. | No. |
---|---|---|
0.099 | 1285 | 1 |
0.100 | 112106 | 4 |
0.105 | 66531 | 3 |
0.110 | 16500 | 2 |
0.115 | 109827 | 3 |
Last trade - 16.10pm 26/08/2024 (20 minute delay) ? |
Featured News
SPL (ASX) Chart |